CHYLOMICRONEMIA SYNDROME DUE TO LIPOPROTEIN-LIPASE (LPL) DEFICIENCY - A POSSIBLE CAUSE OF METABOLIC EMERGENCY

被引:0
|
作者
FERRARIS, S [1 ]
SPADA, M [1 ]
FERRERO, GB [1 ]
DOMPE, C [1 ]
PONZONE, A [1 ]
机构
[1] PEDIAT CLIN,I-10126 TURIN,ITALY
关键词
HYPERTRIGLYCERIDEMIA; CHYLOMICRONEMIA SYNDROME; LPL DEFICIENCY;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Lipoprotein lipase (LPL) plays a major role in the regulation of lipid lipid metabolism. Its primary function is the hydrolysis of triglyceride core of chylomicrons and very low density lipoproteins. In addition, LPL activity allows the maturation of several classes of lipoproteins. Impaired lipolisys due to LPL deficiency causes hypertriglyceridemia and chylomicronemia syndrome. Two primary defects of LPL activity are known, the familial deficiencies of LPL and of apo CII, the natural cofactor of LPL. Circulating inhibitor of LPL has also been reported. Two paradigmatic cases of chylomicronemia syndrome due to familial LPL deficiency are described.
引用
收藏
页码:247 / 252
页数:6
相关论文
共 50 条
  • [1] LIPOPROTEIN-LIPASE (LPL)
    ETIENNE, J
    ANNALES DE BIOLOGIE CLINIQUE, 1984, 42 (03) : 179 - 197
  • [2] ANALYSIS OF THE LIPOPROTEIN-LIPASE GENE IN A PATIENT WITH LPL DEFICIENCY
    BEG, OU
    FOJO, SS
    SKARLATOS, S
    KRUTH, H
    BRUNZELL, J
    BREWER, HB
    ARTERIOSCLEROSIS, 1989, 9 (05): : A708 - A708
  • [3] FAMILIAL CHYLOMICRONEMIA DUE TO A CIRCULATING INHIBITOR OF LIPOPROTEIN-LIPASE ACTIVITY
    BRUNZELL, JD
    MILLER, NE
    ALAUPOVIC, P
    STHILAIRE, RJ
    WANG, CS
    SARSON, DL
    BLOOM, SR
    LEWIS, B
    JOURNAL OF LIPID RESEARCH, 1983, 24 (01) : 12 - 19
  • [4] 2 RFLPS AT THE LIPOPROTEIN-LIPASE (LPL) GENE
    HEGELE, RA
    NAKAMURA, Y
    EMI, M
    LALOUEL, JM
    WHITE, R
    NUCLEIC ACIDS RESEARCH, 1989, 17 (23) : 10146 - 10146
  • [5] TARGETED INACTIVATION OF MURINE LIPOPROTEIN-LIPASE (LPL)
    COLEMAN, T
    SEIP, RL
    MAEDA, N
    SEMENKOVICH, CF
    DIABETES, 1995, 44 : A44 - A44
  • [6] HETEROZYGOUS LIPOPROTEIN-LIPASE DEFICIENCY DUE TO A MISSENSE MUTATION AS THE CAUSE OF IMPAIRED TRIGLYCERIDE TOLERANCE WITH MULTIPLE LIPOPROTEIN ABNORMALITIES
    MIESENBOCK, G
    HOLZL, B
    FOGER, B
    BRANDSTATTER, E
    PAULWEBER, B
    SANDHOFER, F
    PATSCH, JR
    JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (02): : 448 - 455
  • [7] INHIBITION OF LIPOPROTEIN-LIPASE BY UREMIC PLASMA, A POSSIBLE CAUSE OF HYPERTRIGLYCERIDEMIA
    MURASE, T
    CATTRAN, DC
    RUBENSTEIN, B
    STEINER, G
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1975, 24 (11): : 1279 - 1286
  • [8] REGULATION OF THE SECRETION OF LIPOPROTEIN-LIPASE (LPL) BY MOUSE MACROPHAGES
    BEHR, S
    TAVANGAR, K
    KRAEMER, F
    FEDERATION PROCEEDINGS, 1985, 44 (03) : 522 - 522
  • [9] IMMUNO-CYTOCHEMICAL LOCALIZATION OF LIPOPROTEIN-LIPASE (LPL)
    PEDERSEN, M
    COHEN, M
    TWU, JS
    GARFINKEL, AS
    SCHOTZ, MC
    FEDERATION PROCEEDINGS, 1980, 39 (06) : 1726 - 1726
  • [10] FAMILIAL LIPOPROTEIN-LIPASE DEFICIENCY
    BRUNZELL, JD
    AUWERX, JH
    BABIRAK, SP
    DEEB, S
    FUJIMOTO, WY
    HAYDEN, MR
    ATHEROSCLEROSIS VIII, 1989, 817 : 265 - 267